Table 1 Baseline table

Age

31 (25–42)

30 (20–40)

15 (11–21)

28 (17–38)

 Age < 18 years

4 (5%)

5 (10%)

35 (69%)

44 (25%)

 Range

12–68

16–66

5–64

5–68

Male

41 (54%)

32 (67%)

29 (57%)

102 (58%)

Weight (kg)

76 (65–86)

70 (56–80)

55 (40–70)

69 (55–81)

Height (cm)

174 (165–182)

174 (164–182)

162 (150–175)

172 (159–180)

Body surface area (BSA) (m²)

1.9 (1.7–2.1)

1.8 (1.6–2.0)

1.5 (1.3–1.9)

1.8 (1.6–2.0)

Heart rate (beats/min)

68 ± 12

71 ± 12

72 ± 13

70 ± 13

 Tetralogy of Fallot, PA + VSD

20 (26%)

15 (31%)

25 (49%)

60 (34%)

 ASD

2 (3%)

1 (2%)

5 (10%)

8 (5%)

 VSD

0 (0%)

4 (8%)

5 (10%)

9 (5%)

 TGA

6 (8%)

5 (10%)

2 (4%)

13 (7%)

 Valvular disease

28 (37%)

12 (25%)

12 (24%)

52 (30%)

 Turner syndrome

7 (9%)

5 (10%)

0 (0%)

12 (7%)

 Other

4 (5%)

5 (10%)

2 (4%)

11 (6%)

 Healthy volunteer

9 (12%)

1 (2%)

0 (0%)

10 (6%)

 Shunt lesions

1 (1%)

3 (6%)

3 (6%)

7 (4%)

 LV ejection fraction (%)^a

55 (51–59)

55 (47–61)

57 (52–64)

55 (50–61)

 LV end-diastolic volume (ml)^a

155 (130–200)

164 (142–199)

144 (102–177)

155 (124–194)

 LV end-systolic volume (ml)^a

72 (57–89)

76 (58–100)

59 (40–86)

71 (53–89)

 RV ejection fraction (%)^a

52 (47–57)

52 (45–56)

53 (48–59)

52 (47–57)

 RV end-diastolic volume (ml)^a

190 (155–231)

216 (174–279)

170 (131–234)

192 (150–248)

 RV end-systolic volume (ml)^a

93 (67–120)

107 (79–137)

79 (54–117)

95 (63–123)

 Regurgitation

9 (12%)

8 (17%)

3 (6%)

20 (11%)

 Stenosis

2 (3%)

2 (4%)

0 (0%)

4 (2%)

 Bicuspid

14 (18%)

3 (6%)

2 (4%)

19 (11%)

 Biological valve

4 (5%)

0 (0%)

0 (0%)

4 (2%)

 Regurgitation

25 (33%)

21 (45%)

23 (48%)

69 (40%)

 Stenosis

6 (8%)

3 (6%)

2 (4%)

11 (6%)

 Biological valve

10 (13%)

6 (13%)

7 (15%)

23 (13%)

 Aorta (cm²)

5.5 (4.3–7.7)

5.9 (4.7–9.0)

4.7 (3.8–6.1)

5.3 (4.3–7.6)

 Main pulmonary artery (cm²)

6.2 (4.9–7.3)

5.8 (4.7–7.5)

4.9 (4.0–5.8)

5.6 (4.5–7.2)